Clinical Trial Update: Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intermittent sulfadoxine-pyrimethamine for malaria control in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Malaria

Drugs mentioned

• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Bernhard Nocht Institute for Tropical Medicine | Conditions: Malaria, Anemia | Phase 4 | Status: COMPLETED